JP2015154774A5 - - Google Patents

Download PDF

Info

Publication number
JP2015154774A5
JP2015154774A5 JP2015059131A JP2015059131A JP2015154774A5 JP 2015154774 A5 JP2015154774 A5 JP 2015154774A5 JP 2015059131 A JP2015059131 A JP 2015059131A JP 2015059131 A JP2015059131 A JP 2015059131A JP 2015154774 A5 JP2015154774 A5 JP 2015154774A5
Authority
JP
Japan
Prior art keywords
gene
expression
sample
subject
mapk9
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015059131A
Other languages
English (en)
Japanese (ja)
Other versions
JP6178356B2 (ja
JP2015154774A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2015154774A publication Critical patent/JP2015154774A/ja
Publication of JP2015154774A5 publication Critical patent/JP2015154774A5/ja
Application granted granted Critical
Publication of JP6178356B2 publication Critical patent/JP6178356B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2015059131A 2005-03-14 2015-03-23 固形臓器移植レシピエントにおいて移植片生着を評価するための方法および組成物 Expired - Fee Related JP6178356B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66208305P 2005-03-14 2005-03-14
US60/662,083 2005-03-14

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2008501966A Division JP2008537875A (ja) 2005-03-14 2006-03-13 固形臓器移植レシピエントにおいて移植片生着を評価するための方法および組成物

Publications (3)

Publication Number Publication Date
JP2015154774A JP2015154774A (ja) 2015-08-27
JP2015154774A5 true JP2015154774A5 (https=) 2016-02-04
JP6178356B2 JP6178356B2 (ja) 2017-08-09

Family

ID=36992379

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008501966A Pending JP2008537875A (ja) 2005-03-14 2006-03-13 固形臓器移植レシピエントにおいて移植片生着を評価するための方法および組成物
JP2015059131A Expired - Fee Related JP6178356B2 (ja) 2005-03-14 2015-03-23 固形臓器移植レシピエントにおいて移植片生着を評価するための方法および組成物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2008501966A Pending JP2008537875A (ja) 2005-03-14 2006-03-13 固形臓器移植レシピエントにおいて移植片生着を評価するための方法および組成物

Country Status (5)

Country Link
US (2) US7741038B2 (https=)
EP (2) EP2604703B1 (https=)
JP (2) JP2008537875A (https=)
CA (1) CA2601623C (https=)
WO (1) WO2006099421A2 (https=)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002950779A0 (en) * 2002-08-15 2002-09-12 The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland A method of immunomodulation
CA2553551C (en) * 2004-01-21 2020-12-15 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for determining a graft tolerant phenotype in a subject
EP2604703B1 (en) 2005-03-14 2017-02-01 The Board of Trustees of the Leland Stanford Junior University Methods for evaluating graft survival in a solid organ transplant recipient
USRE46843E1 (en) 2005-03-14 2018-05-15 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for evaluating graft survival in a solid organ transplant recipient
EP2066809A2 (en) * 2006-08-28 2009-06-10 Source Precision Medicine Gene expression profiling for identification, monitoring and treatment of transplant rejection
US8003333B2 (en) * 2007-09-28 2011-08-23 Mayo Foundation For Medical Education And Research Serum biomarkers for early detection of acute cellular rejection
EP2088205A1 (en) 2008-02-11 2009-08-12 Institut National De La Sante Et De La Recherche Medicale (Inserm) PSMB10: A diagnosis marker and therapeutic target of chronic rejection.
ES2341419B1 (es) * 2008-08-14 2011-05-03 Hospital Clinic I Provincial De Barcelona Wnt1 como biomarcador de daño renal.
WO2010021696A1 (en) * 2008-08-18 2010-02-25 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for determining a graft tolerant phenotype in a subject
JP2012501456A (ja) * 2008-08-28 2012-01-19 アスチュート メディカル，インコーポレイテッド 腎損傷および腎不全の診断および予後のための方法および組成物
EP2324354B1 (en) * 2008-08-29 2014-07-16 Astute Medical, Inc. Methods for prognosis of acute renal failure
CA2740923A1 (en) * 2008-10-21 2010-04-29 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
ES2836218T3 (es) 2008-10-21 2021-06-24 Astute Medical Inc Procedimientos y composiciones para el diagnóstico y pronóstico de lesión renal e insuficiencia renal
EP2913676A1 (en) 2008-11-10 2015-09-02 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AU2009316387B2 (en) * 2008-11-22 2015-01-29 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP2387618B1 (en) * 2009-01-15 2014-05-21 The Board of Trustees of The Leland Stanford Junior University Biomarker panel for diagnosis and prediction of graft rejection
US9229010B2 (en) 2009-02-06 2016-01-05 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AU2010279249B2 (en) 2009-02-06 2015-08-13 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CA2767616A1 (en) 2009-07-09 2011-01-13 The Scripps Research Institute Gene expression profiles associated with chronic allograft nephropathy
AU2010315008B2 (en) 2009-11-07 2015-12-03 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US20120283123A1 (en) * 2009-11-25 2012-11-08 Sarwal Minnie M Biomarkers for the Diagnosis of Kidney Graft Rejection
US9290813B2 (en) 2009-12-02 2016-03-22 The Board Of Trustees Of The Leland Stanford Junior University Biomarkers for determining an allograft tolerant phenotype
WO2011075744A1 (en) 2009-12-20 2011-06-23 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AU2011213684B2 (en) 2010-02-05 2014-11-20 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ701807A (en) 2010-02-26 2015-05-29 Astute Medical Inc Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2011119980A1 (en) * 2010-03-25 2011-09-29 The Board Of Trustees Of The Leland Stanford Junior University Protein and gene biomarkers for rejection of organ transplants
GB201007454D0 (en) * 2010-05-04 2010-06-16 King S College London Method of determining tolerance
NZ605698A (en) 2010-06-23 2015-03-27 Astute Medical Inc Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US20130210043A1 (en) * 2010-06-23 2013-08-15 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
IN2012MN02812A (https=) * 2010-06-23 2015-05-22 Astute Medical Inc
NZ606124A (en) * 2010-06-23 2015-05-29 Astute Medical Inc Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2012106632A1 (en) * 2011-02-03 2012-08-09 The Board Of Trustees Of The Leland Stanford Junior University Biomarkers for determining an allograft tolerant phenotype
WO2012139051A2 (en) 2011-04-06 2012-10-11 The Board Of Trustees Of The Leland Stanford Junior University Autoantibody biomarkers for iga nephropathy
JP2014531046A (ja) * 2011-10-24 2014-11-20 ソマロジック・インコーポレーテッド 疾病バイオマーカーの同定及び試料品質の評価のための好ましい試料操作及び加工プロトコルの選択
US10935548B2 (en) 2011-12-08 2021-03-02 Astute Medical, Inc. Methods for diagnosis and prognosis of renal injury and renal failure using insulin-like growth factor-binding protein 7 and metalloproteinase inhibitor 2
EP3361255B1 (en) 2013-01-17 2020-03-11 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP3041955A4 (en) * 2013-09-06 2017-05-03 Immucor GTI Diagnostics, Inc. Compositions and methods for diagnosis and prediction of solid organ graft rejection
CN103675300B (zh) * 2014-01-03 2015-10-14 苏州工业园区为真生物医药科技有限公司 Rbx1作为血清标志物的应用及其试剂盒
US11104951B2 (en) 2014-05-22 2021-08-31 The Scripps Research Institute Molecular signatures for distinguishing liver transplant rejections or injuries
US10443100B2 (en) 2014-05-22 2019-10-15 The Scripps Research Institute Gene expression profiles associated with sub-clinical kidney transplant rejection
EP3465201A4 (en) 2016-06-06 2020-08-26 Astute Medical, Inc. MANAGEMENT OF ACUTE KIDNEY DAMAGE USING INSULINOMIMETIC GROWTH FACTOR BINDING PROTEIN 7 AND TISSUE METALLOPROTEINASE 2 INHIBITOR
US10894960B2 (en) 2016-08-30 2021-01-19 Children's Hospital Medical Center Compositions and methods for nucleic acid transfer
PT3510167T (pt) * 2016-09-08 2021-10-18 Inst Nat Sante Rech Med Métodos e composições para prever disfunção crónica de aloenxerto pulmonar
CN110431422A (zh) 2017-02-06 2019-11-08 机敏医药股份有限公司 用于肾损伤和肾衰竭的诊断和预后的方法和组合物
US12411144B2 (en) 2017-03-22 2025-09-09 Children's Hospital Medical Center Compositions and methods for treatment of lung function
WO2019107673A1 (ko) * 2017-11-29 2019-06-06 서울대학교병원 Abo 혈액형 부적합 이식시의 항체-매개성 거부반응의 모니터링을 위한 바이오마커
CN111593113A (zh) * 2020-05-21 2020-08-28 中国科学院大学宁波华美医院 一种基于急性排斥反应新机制的vegf基因结合位点检测方法
WO2022031877A1 (en) * 2020-08-05 2022-02-10 Children's Hospital Medical Center Compositions and methods for the treatment of bronchiolitis obliterans
US12247978B2 (en) * 2020-08-05 2025-03-11 Arizona Board Of Regents On Behalf Of Northern Arizona University Compositions and methods for detection and treatment of coronavirus infection
CN111939272B (zh) * 2020-08-21 2023-02-24 上海交通大学医学院附属第九人民医院 Ccn1的用途
CN116042848B (zh) * 2021-10-28 2024-08-09 北京干细胞与再生医学研究院 一种通过血样检测判断动物体内存在移植物的方法
CN116486922B (zh) * 2023-04-18 2024-01-23 中日友好医院(中日友好临床医学研究所) 一种基于基因多态性及血浆细胞因子的肺移植排斥预测方法及应用

Family Cites Families (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5525464A (en) 1987-04-01 1996-06-11 Hyseq, Inc. Method of sequencing by hybridization of oligonucleotide probes
US5202231A (en) 1987-04-01 1993-04-13 Drmanac Radoje T Method of sequencing of genomes by hybridization of oligonucleotide probes
GB8810400D0 (en) 1988-05-03 1988-06-08 Southern E Analysing polynucleotide sequences
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5800992A (en) 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US6040138A (en) 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
US5547839A (en) 1989-06-07 1996-08-20 Affymax Technologies N.V. Sequencing of surface immobilized polymers utilizing microflourescence detection
EP0430881A3 (en) 1989-11-29 1991-10-23 Ciba-Geigy Ag Photochromic compounds, process for their preparation and their use
US5288644A (en) 1990-04-04 1994-02-22 The Rockefeller University Instrument and method for the sequencing of genome
US5324633A (en) 1991-11-22 1994-06-28 Affymax Technologies N.V. Method and apparatus for measuring binding affinity
ATE173767T1 (de) 1992-04-03 1998-12-15 Perkin Elmer Corp Proben zusammensetzung und verfahren
US5503980A (en) 1992-11-06 1996-04-02 Trustees Of Boston University Positional sequencing by hybridization
US5858659A (en) 1995-11-29 1999-01-12 Affymetrix, Inc. Polymorphism detection
US5470710A (en) 1993-10-22 1995-11-28 University Of Utah Automated hybridization/imaging device for fluorescent multiplex DNA sequencing
GB9401833D0 (en) 1994-02-01 1994-03-30 Isis Innovation Method for discovering ligands
GB9507238D0 (en) 1995-04-07 1995-05-31 Isis Innovation Detecting dna sequence variations
US5661028A (en) 1995-09-29 1997-08-26 Lockheed Martin Energy Systems, Inc. Large scale DNA microsequencing device
JP2002515738A (ja) 1996-01-23 2002-05-28 アフィメトリックス，インコーポレイティド 核酸分析法
EP0937159A4 (en) 1996-02-08 2004-10-20 Affymetrix Inc SPECIATION OF MICROORGANISMS FROM MICROPLATES AND CHARACTERIZATION OF THE PHENOTYPES THEREOF
US5994076A (en) 1997-05-21 1999-11-30 Clontech Laboratories, Inc. Methods of assaying differential expression
JP2001515234A (ja) 1997-07-25 2001-09-18 アフィメトリックス インコーポレイテッド 多型性データベースを提供するためのシステム
US20030104371A1 (en) 1997-09-24 2003-06-05 Strom Terry B. Methods of evaluating transplant rejection
EP1032662B1 (en) 1997-11-07 2006-03-08 Trillium Therapeutics Inc. Methods and compositions for immunomodulation
US6607879B1 (en) 1998-02-09 2003-08-19 Incyte Corporation Compositions for the detection of blood cell and immunological response gene expression
US6429024B1 (en) 1998-03-31 2002-08-06 Asahi Kasei Kabushiki Kaisha Test method for IgA nephropathy
US20050025769A1 (en) 1999-01-22 2005-02-03 Fujisawa Pharmaceutical Company, Ltd. Method of suppressing ongoing acute allograft rejection
AU2002243905B2 (en) 2001-01-26 2007-11-08 Emory University Methods of inducing organ transplant tolerance and correcting hemoglobinopathies
WO2002092124A1 (en) 2001-05-11 2002-11-21 Wyeth Methods for diagnosing and treating ischemia and reperfusion injury and compositions thereof
US7026121B1 (en) 2001-06-08 2006-04-11 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US7235358B2 (en) 2001-06-08 2007-06-26 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US20030022252A1 (en) 2001-07-13 2003-01-30 Thomson Angus W. Method for identifying tolerance in graft recipients
US20070134261A1 (en) 2001-12-03 2007-06-14 Hancock Robert E Effectors of innate immunity
ATE493980T1 (de) 2002-11-21 2011-01-15 Genzyme Corp Verwendung eines diamidderivats zur verhinderung der chronischen transplantatabstossung
EP1599602B1 (en) 2003-02-14 2015-01-14 Beth Israel Deaconess Medical Center, Inc. Predicting graft rejection
US7892745B2 (en) 2003-04-24 2011-02-22 Xdx, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
EP1639090A4 (en) 2003-06-09 2008-04-16 Univ Michigan COMPOSITIONS AND METHODS OF TREATMENT AND DIAGNOSIS OF CANCER
WO2005094200A2 (en) 2003-06-20 2005-10-13 University Of Florida Biomarkers for differentiating between type 2 and type 2 diabetes
US20070111210A1 (en) 2003-12-03 2007-05-17 Marc Bigaud Biomarkers for graft rejection
CA2553551C (en) * 2004-01-21 2020-12-15 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for determining a graft tolerant phenotype in a subject
WO2005074540A2 (en) 2004-01-30 2005-08-18 University Of Pennsylvania Novel predictors of transplant rejection determined by peripheral blood gene-expression profiling
WO2006033664A1 (en) 2004-03-08 2006-03-30 Avalon Pharmaceuticals Determining cancer-linked genes and therapeutic targets using molecular cytogenetic methods
JP2007532506A (ja) 2004-04-08 2007-11-15 ノバルティス アクチエンゲゼルシャフト 自己免疫疾患および拒絶反応の処置のためのタンパク質キナーゼｃ阻害剤
WO2006014755A2 (en) 2004-07-20 2006-02-09 Wyeth Methods of identifying patients at risk of developing encephalitis following immunotherapy for alzheimer’s disease
US7820382B2 (en) 2004-08-03 2010-10-26 Bauer A Robert Method for the early detection of breast cancer, lung cancer, pancreatic cancer and colon polyps, growths and cancers as well as other gastrointestinal disease conditions and the preoperative and postoperative monitoring of transplanted organs from the donor and in the recipient and their associated conditions related and unrelated to the organ transplantation
US20080280282A1 (en) 2004-08-03 2008-11-13 Bauer Jr A Robert Method for early detection of various cancers and gastrointestinal disease and monitoring of transplanted organs
EP2604703B1 (en) 2005-03-14 2017-02-01 The Board of Trustees of the Leland Stanford Junior University Methods for evaluating graft survival in a solid organ transplant recipient
US7666596B2 (en) 2005-05-23 2010-02-23 University Of Alberta Tissue rejection
EP1731620A1 (en) 2005-06-07 2006-12-13 Institut National De La Sante Et De La Recherche Medicale (Inserm) Method for the diagnosis of immune graft tolerance
US20090118162A1 (en) 2005-06-07 2009-05-07 Regents Of The University Of Colorado Inhibitors of serine protease activity and their use in methods and compositions for treatment of graft rejection and promotion of graft survival
CA2611728A1 (en) 2005-06-08 2006-12-14 Millennium Pharmaceuticals, Inc. Methods for the identification, assessment, and treatment of patients with cancer therapy
WO2007050588A2 (en) 2005-10-25 2007-05-03 Renovar Incorporated Systems and methods for characterizing conditions of organs for transplantation
CN101416063A (zh) 2006-02-06 2009-04-22 拉帕波特家族医学科学研究所 用于诊断t1dm的方法和试剂盒
GB0605217D0 (en) 2006-03-15 2006-04-26 Novartis Ag Method and compositions for assessing acute rejection
WO2007112097A2 (en) 2006-03-24 2007-10-04 Children's Medical Center Corporation Novel signature self renewal gene expression programs
GB0607943D0 (en) 2006-04-21 2006-05-31 Novartis Ag Biomarkers for chronic transplant dysfunction
CA2650507A1 (en) 2006-04-27 2007-11-08 Universite De Montreal Assessment and reduction of risk of graft-versus-host disease
WO2008084331A2 (en) 2006-06-21 2008-07-17 Hopitaux Universitaires De Geneve Biomarkers for renal disorders
US20090176656A1 (en) 2006-07-21 2009-07-09 Halloran Philip F Tissue rejection
EP2066809A2 (en) 2006-08-28 2009-06-10 Source Precision Medicine Gene expression profiling for identification, monitoring and treatment of transplant rejection
ES2324751B1 (es) 2007-01-04 2010-05-31 Institut D'investigacions Biomediques August Pi I Sunyer (Idibaps) Metodos y kits para diagnosticar y/o pronosticar el estado de tolerancia en el trasplante de higado.
WO2008091814A2 (en) 2007-01-22 2008-07-31 Wyeth Assessment of asthma and allergen-dependent gene expression
US20100234292A1 (en) 2007-04-16 2010-09-16 Ipsogen Methods of assessing a propensity of clinical outcome for a female mammal suffering from breast cancer
US20100305188A1 (en) 2007-10-03 2010-12-02 Kyowa Hakko Kirin Co., Ltd. Nucleic acid capable of regulating the proliferation of cell
WO2009124404A1 (en) 2008-04-09 2009-10-15 The University Of British Columbia Methods of diagnosing acute cardiac allograft rejection
WO2009143624A1 (en) 2008-05-30 2009-12-03 The University Of British Columbia Methods of diagnosing rejection of a kidney allograft using genomic or proteomic expression profiling
KR101644120B1 (ko) 2008-06-02 2016-07-29 에디아 가부시키가이샤 ＩｇＡ 신증의 검사 방법 및 검사 키트
WO2010021696A1 (en) 2008-08-18 2010-02-25 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for determining a graft tolerant phenotype in a subject
KR100928403B1 (ko) 2008-10-01 2009-11-26 경북대학교 산학협력단 티지비엠 신증의 진단용 조성물 및 키트
EP2387618B1 (en) 2009-01-15 2014-05-21 The Board of Trustees of The Leland Stanford Junior University Biomarker panel for diagnosis and prediction of graft rejection
US8734786B2 (en) 2009-09-16 2014-05-27 Northwestern University Use of ECDI-fixed cell tolerance as a method for preventing allograft rejection
WO2011142900A1 (en) 2010-05-13 2011-11-17 University Of Medicine And Dentistry Of New Jersey Diagnostic autoantibody profiles for the detection and diagnosis of neurodegenerative diseases

Similar Documents

Publication Publication Date Title
JP2015154774A5 (https=)
Picard et al. Markers of survival and metastatic potential in childhood CNS primitive neuro-ectodermal brain tumours: an integrative genomic analysis
ES2659487T5 (en) Size-based analysis of fetal dna fraction in maternal plasma
WO2018007872A9 (en) Biomarkers for inflammatory bowel disease
JP2016500110A5 (https=)
JP2018537128A5 (https=)
WO2016049932A1 (en) Biomarkers for obesity related diseases
JP2018504138A5 (https=)
CN105473738B (zh) 结直肠癌生物标志物
IL320112A (en) Methods and processes for non-invasive assessment of genetic variations
JP2017522908A5 (https=)
TWI679280B (zh) 一種膀胱癌的無創檢測及其復發監測方法
JP2013509870A5 (https=)
JP2016525355A5 (https=)
CN103797366A (zh) 免疫多样性评估方法及其用途
TW201814290A (zh) 一種鑑定樣本中腫瘤負荷的方法和系統
JP2019527039A5 (https=)
CN112424372A (zh) 用于监测器官健康和疾病的方法和系统
JP2019510473A5 (https=)
JP2018046826A5 (https=)
CN115449542A (zh) 用于测量个体的免疫组库的变化的方法
Hyduke et al. Identifying radiation exposure biomarkers from mouse blood transcriptome
Das et al. Genome-wide association studies for bivariate sparse longitudinal data
WO2016049927A1 (en) Biomarkers for obesity related diseases
TWI626314B (zh) 評估罹患大腸直腸癌風險的方法